These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1874479)

  • 1. Does interferon-beta therapy induce thyroid autoimmune phenomena?
    Pagliacci MC; Pelicci G; Schippa M; Liberati AM; Nicoletti I
    Horm Metab Res; 1991 Apr; 23(4):196-7. PubMed ID: 1874479
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferons.
    Silvestri F; Virgolini L; Mazzolini A; Bertolissi F; Russo D; Fanin R; Baccarani M
    Haematologica; 1994; 79(4):367-70. PubMed ID: 7806093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C.
    Watanabe U; Hashimoto E; Hisamitsu T; Obata H; Hayashi N
    Am J Gastroenterol; 1994 Mar; 89(3):399-403. PubMed ID: 8122653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmune dysthyroidism induced by alpha interferon in two female patients with chronic non-A, non-B hepatitis].
    Eugène C; Tennenbaum R; Anciaux ML; Quevauvilliers J; Bergue A
    Gastroenterol Clin Biol; 1993; 17(8-9):594-7. PubMed ID: 8253318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].
    Gutkowski K; Gutkowska D; Bilkiewicz T
    Przegl Lek; 2007; 64(3):148-52. PubMed ID: 17941466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid autoimmunity and dysfunction associated with type I interferon therapy.
    Monzani F; Caraccio N; Dardano A; Ferrannini E
    Clin Exp Med; 2004 Apr; 3(4):199-210. PubMed ID: 15103510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Appearance of immune thyroid diseases during beta-interferon therapy of multiple sclerosis].
    Buchinger W; Niederwieser G; Rainer F
    Dtsch Med Wochenschr; 1999 Dec; 124(48):1473. PubMed ID: 10615332
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disclosure of autoimmune hepatitis by interferon].
    Payen JL; Rabbia I; Combis M; Voigt JJ; Vinel P; Pascal JP
    Gastroenterol Clin Biol; 1993; 17(5):404-5. PubMed ID: 8349084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Autoimmunity in thyroid disease secondary to amiodarone: heredofamilial aspects].
    Olguín R; Nungaray L; Reyes PA; Molina L; Cardoso G; Boyer JL; Baltazares E; Posadas C
    Arch Inst Cardiol Mex; 1988; 58(3):197-202. PubMed ID: 3214217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunologic aspects of the relation of acquired leukoderma (vitiligo) to thyroid diseases.
    Miklaszewska M; Zukowski W; Dankiewicz J; Nowak A
    Arch Immunol Ther Exp (Warsz); 1972; 20(6):885-92. PubMed ID: 4123759
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.
    Dumoulin FL; Leifeld L; Sauerbruch T; Spengler U
    Biomed Pharmacother; 1999 Jun; 53(5-6):242-54. PubMed ID: 10424246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of abnormal thyroid function tests in Kuwaiti Arabs with autoimmune diseases.
    Al-Awadhi AM; Olusi S; Hasan EA; Abdullah A
    Med Princ Pract; 2008; 17(1):61-5. PubMed ID: 18059103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Occurrence of primary hypothyroidism in alpha-interferon treatment].
    Saglietti G; Ferrari V; Luraschi A; Ripamonti G; Gioria A; Fedeli P; Bersi M
    Recenti Prog Med; 1996; 87(7-8):342-5. PubMed ID: 8975336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thyroid function in patients treated with lithium carbonate].
    Lucas A; Sanmartí A; Catalán R; Galard R; Castellanos JM; Martínez-Pina A; Foz M
    Med Clin (Barc); 1984 Sep; 83(7):280-2. PubMed ID: 6436593
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-A2 subtype in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
    Kakizaki S; Takagi H; Murakami M; Takayama H; Sato K; Mori M
    Liver; 2000 Oct; 20(5):423-4. PubMed ID: 11092263
    [No Abstract]   [Full Text] [Related]  

  • 16. Disturbances in the thyroid function during the treatment with the para-aminosalicylic acid derivatives.
    Górowski T; Gasiorowski W
    Pol Med J; 1968; 7(3):638-42. PubMed ID: 5669704
    [No Abstract]   [Full Text] [Related]  

  • 17. [Levels of immunoglobulins A, G and M, and beta-1-C/beta-1-A globulin in the serum of patients with autoimmune thyroid gland diseases (author's transl)].
    Engelberth O; Límanová Z; Malíková J
    Sb Lek; 1977 Aug; 79(7-8):206-9. PubMed ID: 71755
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
    Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
    Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes mellitus type I, thyroid gland autoimmunity, thyroid gland function and HLA status].
    Kehr S; Gastauer R; Winkler G
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):738-42. PubMed ID: 3906379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver damage during interferon therapy for chronic myeloid leukaemia.
    Philippe P; Fialip J; Souweine B; Aumaitre O; Marcheix JC; Lavarenne J
    Eur J Med; 1993; 2(7):446. PubMed ID: 8258041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.